Recent insider trading activity from Giladi Moshe, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2024 | NovoCure Ltd | $NVCR | Giladi Moshe | Chief Science Officer | A | Ordinary Shares | 51124 | $16.30 | 69,771.0000 | 0 | 274.17% | 0.00% |
| Feb. 27, 2024 | NovoCure Ltd | $NVCR | Giladi Moshe | Chief Science Officer | A | Stock Options (Right to buy) | 78174 | $16.30 | 78,174.0000 | 0 | 9999.99% | 0.00% |